27.11.2012 Views

BioWorld® - Medical Device Daily

BioWorld® - Medical Device Daily

BioWorld® - Medical Device Daily

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

BioWorld Industrial Biotechnology StatReport: Immediate and Comprehensive Industry Information<br />

Joint venture with Cargill to use biotechnology to improve feed for pigs,<br />

cattle, poultry and fish (5/98)<br />

Formed American Seeds Inc. (ASI), a holding company to support regional<br />

seed businesses (11/04)<br />

BUSINESS STRATEGY: Produce leading seed brands and develop biotechnology traits that assist<br />

farmers in controlling insects and weeds<br />

Provide other seed companies with genetic material and biotechnology traits<br />

for their seed brands<br />

Provide lawn-and-garden herbicide products for the residential market<br />

Provide animal agricultural products focused on improving dairy cow<br />

productivity and swine genetics<br />

AGREEMENTS: Name Products Content of Agreement Date<br />

Genaissance to map single nucleotide research agreement 3/05<br />

Pharmaceuticals polymorphism (SNP)<br />

Inc. and the DNA markers in<br />

Agricultural<br />

Research Service<br />

(part of USDA)<br />

soybeans<br />

Agracetus Inc. transgenic cotton purchased all plant 4/96<br />

technology<br />

biotech assets from<br />

W.R. Grace & Co<br />

Arcadia<br />

development and licensing agreement 9/05<br />

Biosciences Inc. commercialization of<br />

Arcadia's nitrogen use<br />

efficiency technology in<br />

canola<br />

ArQule Inc. agrochemicals development<br />

agreement<br />

12/96<br />

Calgene Inc. fresh produce and plant<br />

oils<br />

R&D agreement 10/95<br />

Calgene Inc. oilseed research cross-licensing 5/96<br />

programs<br />

agreement--<br />

Calgene will receive<br />

royalty-free license<br />

to current and<br />

future Monsanto<br />

agronomic<br />

technology in<br />

combination with<br />

Calgene's oils<br />

modification genes.<br />

Monsanto will pay<br />

Calgene royalties<br />

and $17M and will<br />

receive portion of<br />

profits of Calgene's<br />

specialty oils<br />

business<br />

Calgene Inc. patented technologies cross-licensing<br />

agreements--<br />

Monsanto received<br />

licenses to<br />

Calgene's patents<br />

and patents<br />

pending in the<br />

areas of plant<br />

transformation,<br />

certain genetically<br />

engineered plants,<br />

and antisense RNA<br />

technology.<br />

Calgene received<br />

licenses to<br />

4/93<br />

Copyright ©2006 AHC Media ® 249

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!